![](/img/cover-not-exists.png)
Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma : Pooled analysis of 2 consecutive trials
Francesco Boccardo, Alessandra Rubagotti, Daniela Aldrighetti, Franco Buzzi, Giorgio Cruciani, Antonio Farris, Giorgio Mustacchi, Mauro Porpiglia, Giorgio Schieppati, Piero SismondiVolume:
109
Year:
2007
Pages:
8
DOI:
10.1002/cncr.22513
File:
PDF, 171 KB
2007